240 likes | 344 Views
Explore the latest tools and outcomes in addressing angina, with focus on nonflow-limiting lesions, PCI vs. medical therapy, and age-related issues in women. Learn about reducing A1c with Ranolazine and care planning for chronic stable coronary artery disease.
E N D
Angina in the United States: Morbidity and Age-Related Issues
Nonflow-Limiting Lesions Are the Principal Progenitors of Most Acute MI Events
Meta-analysis of PCI vs Medical Therapy Trials: Death and Nonfatal MI Outcomes
Chronic Stable Coronary Artery Disease Performance Measurement Set
Reductions in A1c Seen With Ranolazine Use in Randomized Trials
Microvascular Coronary Dysfunction in Women With Angina and Ischemia, but no Obstructive CAD
WISE: 5-Year Rates of CV Outcomes in Symptomatic Women With No CAD vs Nonobstructive CAD
DASI: Measures Functional Capacity and Assesses Aspects of Quality of Life